Clinical Trials Advancement and Methods & Diversity and Disparities PIAs: Increasing sustained diversity in Alzheimer's disease and related dementia clinical trials.

Recorded: May 23, 2022

There is a need for AD clinical trials to improve recruitment, enrollment, and retention of diverse populations to ensure potential treatments are safe, effective, accessible, and equitable. Globalization of AD clinical trials is also discussed.

Moderators: Ganesh M Babulal, Jorge J Llibre-Guerra

Panelists: Erin Abner, Rufus Akinyemi, Suvarna Alladi, Sonia Brucki, Stephanie Monroe, Rema Raman

Closing Remarks: Bruce Miller